chicago_biz
12 records
Chicago License: CENTRAL ADMIXTURE PHARMACY SERVICES INC.
Limited Business License | Pharmacy / Photo Services | Retail Sales of General Merchandise and Non-Perishable Food
View Source
Chicago License: CENTRAL ADMIXTURE PHARMACY SERVICES INC.
Limited Business License | Pharmacy / Photo Services | Retail Sales of General Merchandise and Non-Perishable Food
View Source
Chicago License: CENTRAL ADMIXTURE PHARMACY SERVICES INC.
Limited Business License | Pharmacy / Photo Services | Retail Sales of General Merchandise and Non-Perishable Food
View Source
Chicago License: CENTRAL ADMIXTURE PHARMACY SERVICES INC.
Limited Business License | Pharmacy / Photo Services | Retail Sales of General Merchandise and Non-Perishable Food
View Source
co_sos
1 records
CO Business: CENTRAL ADMIXTURE PHARMACY SERVICES, INC.
1997-05-16
FPC | Status: Good Standing | IRVINE, CA
View Source
fda
345 records
FDA Drug Recall: PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only
2025-03-19
Class I — Presence of Particulate Matter
View Source
FDA Drug Recall: fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAPS I
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL, 5,000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, R
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL, 1,250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixtur
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volu
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx onl
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: PHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syringe,
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: PHENYLephrine in 0.9 sodium chloride, 400 mcg/10 mL, (40 mcg/mL), 10 mL Syringe,
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx onl
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS I
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Vo
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CA
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe,
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Centra
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Cen
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Se
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe,
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volu
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: PHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syri
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: HYDROmorphone in dextrose 5%, 0.5 mg/5 mL, (0.1 mg/mL), 5 mL Syringe, Rx only, C
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Adm
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 D
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: HYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: ePHEDrine in 0.9% sodium chloride, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: rocuronium, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pha
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, C
2023-10-11
Class II — Lack of assurance of sterility:
View Source
FDA Drug Recall: EPINEPHrine added to dextrose 5%, 4mg/250ml (16 mcg/mL), IV Bag, Rx Only, Centra
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag,
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with HEPARI
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: heparin added to 0.9% sodium chloride, 2500 units/500mL (5 units/mL), IV Bag, Rx
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10%, Total Volu
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine added to 0.9% sodium chloride 50 mg/250mL (200mcg/mL), IV Bag, Rx
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3% / Dextrose 10%, Total Volu
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with **low ca
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1, Plasmalyte/Tromethamine, High Pota
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5% / Dextrose 10% with **lo
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL, IV Bag, Rx only, CAPS, C
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine added to 0.9% sodium chloride, 20mg/250ml (80 mcg/mL), IV Bag, Rx
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine, added to 0.9% sodium chloride, 10mg/250ml (40mcg/mL), IV Bag, Rx
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride, IV Bag, Rx Only
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 4%/Dextrose 10% with CALCIUM
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 25 mEq K, SUTTER CARDIOPLEGIA, Total Volume = 572.64 mL,
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: vancomycin added to 0.9% Sodium Chloride, 1.25 g/250 mL (5 mg/mL), 250mL Excel B
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, HIGH POTASSIUM, Total Volume = 8
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: oxyTOCIN 30 units added to Lactated Ringer's 500 mL, IV Bag, Rx only, Cental Adm
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: oxyTOCIN, 40 units added to 0.9% sodium chloride 1000 mL, IV Bag, Rx Only, Centr
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine 1,000 mcg/10mL, (100mcg/mL) in 0.9% sodium chloride, 10 mL Syringe
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: rocuronium 50 mg/5 mL (10 mg/mL), 5 mL Syringes, Rx only, this drug was repackag
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2.5%/Dextrose 10% with CALCIU
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine, added to 0.9% sodium chloride, 40mg/250ml (160mcg/mL), IV Bag, Rx
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Cardioplegia Solution del Nido Formula, Total Volume = 1,052.8 mL, EVA Bag, PLAS
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, Total Volume =
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with CALCIUM
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, Total volume =
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: dilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%, IV Bag, RX only, Central
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Cardioplegia Solution, low K, Maintenance 4:1 Plasmalyte, Low Potassium, total v
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: EPINEPHrine added to 0.9% sodium chloride, 4mg/250mL (16 mcg/mL), IV Bag, RX onl
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIUM a
2023-09-06
Class II — Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIUM,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 1.5 g/250mL added to 5% dextrose, 6 mg/mL, IV Bag, Rx only, Cental Ad
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe,
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: morphine in 0.9% sodium chloride, 125 mg/25 mL, (5 mg/mL), 30 mL Syringe, Rx onl
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 5000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx o
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Centr
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 108 mEq K, Induction 8:1, High Potassium, IV Bag, total v
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture P
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: oxyTOCIN 30 units added to Lactated Ringer's 500 mL, IV Bag, Rx only, Rx only, C
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with **low cal
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 15 mEq K, Reperfusate 4:1, low potassium, IV Bag, total
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: HYDROmorphone added to 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 100 mL ba
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Se
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syringe
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 48 mEq K, Induction 4:1 in Ringer's, High Potassium, IV B
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: phenylephrine, 25mg added to 0.9% sodium chloride 250 mL, IV Bag, Rx Only, Cent
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN 30 units added to dextrose 5%/lactated ringers 500 mL, IV Bag, Rx Only,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: phenylephrine 50 mg added to 0.9% sodium chloride 250mL, CONCENTRATION = 200mcg/
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: morphine in 0.9% sodium chloride, 1 mg/1 mL, (1 mg/mL), 3 mL Syringe, Rx only, C
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, IV Bag, total
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10% with CALCIUM,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 750 mg/250 mL added to 0.9% Sodium Chloride, (3 mg/mL), IV Bag, Rx on
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx onl
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: morphine in 0.9% Sodium Chloride, 50 mg/50 mL (1mg/mL), 50 mL Syringe, Rx only,
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION 122 mEq K, Modified St. Thomas Formula High Potassium, Tot
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 100 mEq K, Induction 8:1, High Potassium / Low dextrose,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: PHENYLephrine, 40mg/250ml, added to 0.9% sodium chloride, IV Bag, Rx Only, Centr
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1 Plasmalyte, High Potassium, IV Bag,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: heparin 5000 units/500mL added to 0.9% sodium chloride, 10 units/mL, IV Bag, Rx
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volu
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10%, total volu
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10%, total volume
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Cen
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 1000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx o
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1 non-enriched, Low Potassium, IV
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 6%/Dextrose 10% with low calc
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 36 mEq K, Induction 4:1, High Potassium/Low tromethamine,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, CAP
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 4%/Dextrose 10% with CALCIUM
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, IV Bag, Total Volume = 1818 mL, CRYSTALLOID INDUCTION, Rx
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 1 g/250 mL added to 0.9% sodium chloride, 4 mg/mL, IV Bag, Rx only,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, LEESBURG CARDIOPLEGIA, IV Bag, Total Volume = 1030.2 mL,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL syrin
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, C
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx o
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Vol
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe,
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with **low
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL, IV Bag, Rx only, Centa
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL, IV Bag, Rx only, Cental
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: potassium phosphate 15 mmole added to 0.9% sodium Chloride 250 mL, IV Bag, RX On
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volum
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, IV Bag, total v
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 mcg
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: heparin 4000 units/1000mL added to 0.9% sodium chloride, 4 units/mL, IV Bag, Rx
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL, IV Bag, Rx o
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: heparin 7500 units added to 0.9% sodium chloride 1000mL, CONCENTRATION = 7.5 uni
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: HYDROmorphone in Dextrose 5%, 0.5 mg/5 mL (0.1 mg/mL), 5 mL Syringe, Rx only, CA
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: dilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%, IV Bag, RX only, Central
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Central Admixture Ph
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, High Potassium, IV Bag, total vo
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: heparin 2500 units/500mL added to 0.9% sodium chloride 5 units/mL, IV Bag, Rx on
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with CALCIUM,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride, IV Bag, Rx Only
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 1.5 g/250 mL added to 0.9% sodium chloride, 6 mg/mL, IV Bag, Rx only,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1, Plasmalyte/Tromethamine, High Pota
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN, 40 units added to 0.9% sodium chloride 1000 mL, IV Bag, Rx Only, Rx on
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10%, Total Volume
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIUM a
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: PHENYLephrine 20mg/250ml added to 0.9% sodium chloride, IV Bag, Rx Only, Central
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repacka
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 1.5 g/500 mL added to 0.9% sodium chloride, 3 mg/mL, IV Bag, Rx only,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volu
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: oxyTOCIN 20 units added to Lactated Ringer's 1000 mL, IV Bag, Rx only, Central A
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, R
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine in 0.9 sodium chloride, 400 mcg /10 mL, (40 mcg/mL), 10 mL Syringe
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, C
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with HEPARI
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with CALCIU
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: potassium phosphate, 30 mmole added to 0.9% sodium Chloride 500mL, IV Bag, RX On
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 12 mEq K, Maintenance 4:1 in Ringer's Low Potassium, IV B
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 106 mEq K, Modified St. Thomas Solution High Potassium H
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: heparin 2500 units added to 0.9% sodium chloride 250mL, CONCENTRATION = 10 units
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: morphine in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: EPINEPHrine 4mg/250mL added to 0.9% sodium chloride, IV Bag, RX only, Central Ad
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, low K, Maintenance 4:1 Plasmalyte/Tromethamine, Low Potas
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with **low ca
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 15 mEq K, Reperfusate 4:1, low potassium/low tromethamine
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 70 mEq K, Modified St. Thomas Formula low potassium, IV B
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: PHENYLephrine, 10mg/250ml added to 0.9% sodium chloride, 40mcg/mL, IV Bag, Rx On
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with CALCIU
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN, 20 units added to dextrose 5%/lactated ringers 1000 mL, IV Bag, Rx Onl
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION 40 mEq K, Warm Induction 4:1 High Potassium, IV Bag, total
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 25 mEq K, SUTTER CARDIOPLEGIA, IV Bag, Total Volume = 572
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10% with **low ca
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with CALCIUM
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: rocuronium, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Ph
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 2.5%/Dextrose 10%, total volu
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx onl
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Cardioplegia Solution, low K, Maintenance 4:1 Plasmalyte, Low Potassium, IV Bag,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 36 mEq K, Maintenance 8:1, low Potassium / low dextrose,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: EPINEPHrine 8mg/250ml added to dextrose 5%, 32 mcg/mL, IV Bag, Rx Only, Central
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Ph
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: PHENYLephrine 1,000 mcg/10mL, (100mcg/mL) in 0.9% sodium chloride, Syringe, Rx O
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: neostigmine 5 mg/5mL (1mg/mL) Syringe, Rx only, This drug was repacked by CAPS,
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 1.75g added to 0.9% sodium chloride 500mL, IV Bag, Rx only, Cental A
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: ePHEDrine in 0.9% sodium chloride, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx onl
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 5% with CALCIUM a
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10% with CALCIUM
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 4%/Dextrose 10%, total volume
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by C
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 2 g/500 mL added to 0.9% Sodium Chloride, 4 mg/mL, IV Bag, Rx only, C
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL, IV Bag, Rx only, This dr
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: TRANSPLANT SOLUTION, Plasma-Lyte A - 75 ml, MSA/MSG 0.92 Molar -60 ml, dextrose
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Cardioplegia Solution del Nido Formula, IV Bag, Total Volume = 1,052.8 mL, FOR I
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN 15 units added to Lactated Ringer's 250 mL, IV Bag, Rx only, Cental Adm
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: oxyTOCIN 10 units added to Lactated Ringer's 500 mL, IV Bag, Rx only, Cental Adm
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, Central Admixture
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2.5%/Dextrose 10% with CALCIU
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 1.25 g/250 mL added to dextrose 5%, 5 mg/mL, IV Bag, Rx only, Central
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: EPINEPHrine added to dextrose 5%, 4mg/250ml, IV Bag, Rx Only, Central Admixture
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (trophamine) 6%/Dextrose 10% with CALCIUM
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx
2023-08-09
Class II — Lack of assurance of sterility: Lack of validation data for sanitization cycles
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 30 mEq K, Induction 4:1, High Potassium, IV Bag, total vo
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 70 mEq K, Induction 8:1, non-enriched, High Potassium, IV
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vancomycin 1.25 g/250 mL added to 0.9% Sodium Chloride, 5 mg/mL, IV Bag, Rx only
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: CARDIOPLEGIA SOLUTION, 7.5 mEq K, Reperfusate 4:1, low potassium, IV Bag, total
2023-08-09
Class II — Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
View Source
FDA Drug Recall: vasopressin 20 units added to 0.9% sodium chloride 100 mL*, 0.2 units/mL*, 100 m
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Maintenance 4:1 Plasma-Lyte/Tromethamine, low potassium,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10%, packaged i
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Warm Induction 4:1 HIGH POTASSIUM/low tromethamine, 40 mE
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: MSA 7.84% MSG 8.56% (0.92M) Comp. Sol. 1000 ml bag, Rx only, Central Admixture P
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to 0.9% sodium chloride, 2 g/500 mL* (4 mg/mL), 500 mL per bag,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: diphenhydrAMINE 50 mg added to 0.9% sodium chloride 50 mL in 100 mL Partial Addi
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 8:1 non-enriched, HIGH POTASSIUM, 70 mEq K, pac
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: potassium phosphate 30 mmole added to 0.9% sodium chloride 500 mL per bag, Rx on
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: NORepinephrine added to dextrose 5%, 16 mg/250 mL* (64 mcg/mL), 250 mL per bag,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4.5%/Dextrose 10% with HEPARI
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with low calci
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Maintenance 4:1 in Ringer's, low potassium, 12 mEq K, pac
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: EPINEPHrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL per
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCIUM
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 6%/Dextrose 10% with CALCIUM
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 8:1 High Potassium/low dextrose, 100 mEq K, pac
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to 0.9% sodium chloride, 1.5 g/250 mL* (6 mg/mL), 250 mL per ba
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: EPINEPHrine added to dextrose 5%, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx o
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Microplegia Solution, MSA/MSG 0.92 Molar with CP2D, packaged in 120 mL per bag,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Transplant Solution (Plasma-Lyte A), packaged in 165 mL per bag, Rx only, Centra
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vasopressin 40 units added to 0.9% sodium chloride 100 mL*, 0.4 units/mL*, 100 m
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: heparin added to 0.9% sodium chloride, 2,500 units/250 mL* (10 units/mL), 250 mL
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: HyperLyte CR Injection, 250 mL bag, Rx only, Central Admixture Pharmacy Services
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to 0.9% sodium chloride, 1 g/250 mL* (4 mg/mL), 25 250 mL per b
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 4:1 in Ringer's, HIGH POTASSIUM, 48 mEq K, pack
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 40 units added to 0.9% sodium chloride 1,000 bag, Rx only, Central Admi
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Reperfusate No Potassium, packaged in 477.5 mL per bag, R
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: heparin added to 0.9% sodium chloride, 2,500 units/500 mL* (5 units/mL), 500 mL
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: HyperLyte CR Injection, 500 mL bag, Rx only, Central Admixture Pharmacy Service
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: norepinephrine 4 mg added to dextrose 5% 250 mL*, 16 mcg/mL, 250 mL per bag, Rx
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 4:1, High Potassium, 60 mEq K, packaged in 830
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 4:1 High Potassium, 30 mEq K, packaged in 415 m
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 20 units added to dextrose 5%/Lactated Ringer's 1,000 mL per bag, Rx on
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: EPINEPHrine added to dextrose 5%, 2 mg/250 mL* (8 mcg/mL), 250 mL per bag, Rx on
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Maintenance 8:1 low potassium, 24 mEq K, packaged in 500
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCIUM,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Modified St Thomas Solution, HIGH POTASSIUM, HIGH SODIUM
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Modified St Thomas Formula, low potassium, 70 mEq K, pack
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 6%/Dextrose 10% with low calc
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2.5%/Dextrose 10% with CALCIU
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Maintenance 4:1 low potassium/low tromethamine, 36 mEq K,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10% with low calc
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Microplegia (MSA/MSG 0.92 Molar) packaged in 125 mL per bag, Rx only, Central Ad
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: NORepinephrine added to 0.9% sodium chloride, 8 mg/250 mL* (32 mcg/mL), 250 mL p
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to dextrose 5%, 1.5 g/250 mL* (6 mg/mL), 250 mL per bag, Rx onl
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Modified St Thomas Formula, HIGH POTASSIUM, 122 mEq K, pa
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10%, packaged in
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), 250 mL
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 30 units added to Lactated Ringer's 500 mL per bag, Rx only, Central Ad
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: NORepinephrine added to 0.9% sodium chloride, 16 mg/250 mL* (64 mcg/mL), 250 mL
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with CALCIUM,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Reperfusate 4:1 low potassium/low tromethamine, 15 mEq K,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Centr
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10% with CALCIUM
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 10 units added to Lactated Ringer's 500 mL per bag, Rx only, Central Ad
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Warm Induction 4:1 High Potassium (40 mEq) packaged in 50
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Reperfusate 4:1 low potassium, 15 mEq K, packaged in 477.
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 15 units added to Lactated Ringer's 250 mL per bag, Rx only, Central Ad
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 20 units added to Lactated Ringer's 1,000 mL per bag, Rx only, Central
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL per bag, Rx only, Central
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: potassium phosphate 15 mmole added to 0.9% sodium chloride 250 mL per bag, Rx on
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Microplegia Solution, HIGH POTASSIUM (100 mEq), packaged in 200 mL per bag, Rx o
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to 0.9% sodium chloride, 750 mg/250 mL* (3 mg/mL), 250 mL per b
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: heparin added to 0.9% sodium chloride, 4,000 units/1,000 mL* (4 units/mL), 1,000
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with low calc
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with CALCIU
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: phenylephrine 50 mg added to 0.9% sodium chloride 250 mL*, 200 mcg/mL*, 250 mL p
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to 0.9% sodium chloride, 1.25 g/250 mL* (5 mg/mL), 250 mL per b
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: diphenhydrAMINE 25 mg added to 0.9% sodium chloride 50 mL in 100 mL Partial Addi
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10%, packaged in
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Maintenance 4:1 Plasmalyte, low potassium, low K, package
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 4:1 Plasma-Lyte/Tromethamine, High Potassium, p
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to 0.9% sodium chloride, 1.75 g/500 mL* (3.5 mg/mL), 500 mL per
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to dextrose 5%, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx on
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: PHENYLephrine added to 0.9% sodium chloride, 10 mg/250 mL* (40 mcg/mL), 250 mL p
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Maintenance 4:1 low potassium, 20 mEq K, packaged in 810
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Reperfusate No Potassium, packaged in 238.75 mL per bag,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 4:1, HIGH POTASSIUM/low tromethamine, 36 mEq K,
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with CALCIUM a
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 8:1 High Potassium, 108 mEq K, packaged in 500
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10% with CALCIUM
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vasopressin 50 units added to 0.9% sodium chloride 50 mL*, 1 unit/mL*, 50 mL in
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: NORepinephrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL p
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 30 units added to dextrose 5%/Lactated Ringer's 500 mL per bag, Rx only
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with CALCIU
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Lidocaine 2% HCl Inj, 500mL bag, Rx only, Central Admixture Pharmacy Services, 6
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: EPINEPHrine added to dextrose 5%, 8 mg/250 mL* (32 mcg/mL), 250 mL per bag, Rx o
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: dilTIAZem added to dextrose 5%, 125 mg/125 mL* (1 mg/mL), 125 mL per bag, Rx onl
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Sodium Phosphates Injection 4 mEq/3 mMol/mL, 500 ml bag, Rx only, Central Admixt
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Reperfusate 4:1 low potassium, 7.5 mEq K, packaged in 238
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: PHENYLephrine added to 0.9% sodium chloride, 25 mg/250 mL* (100 mcg/mL), 250 mL
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Potassium Acetate Injection, 2 mEq/mL, 500 ml bag, Rx only, Central Admixture Ph
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: vancomycin added to 0.9% sodium chloride, 1.5 g/500 mL* (3 mg/mL), 500 mL per ba
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Maintenance 8:1 non-enriched, low potassium, 24 mEq K, pa
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: heparin added to 0.9% sodium chloride, 5,000 units/500 mL* (10 units/mL), 500 mL
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Induction 4:1 Plasmalyte, HIGH POTASSIUM, HIGH K, package
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: tromethamine 0.3 Molar, 50 mL syringe, Rx only, Central Admixture Pharmacy Servi
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL per bag, Rx only, Central
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, Modified St Thomas Solution, low potassium, HIGH SODIUM B
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, del Nido Formula, packaged in 1,052.8 mL per bag, Rx only
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Neonatal PN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with low cal
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Cardioplegia Solution, LEESBURG CARDIOPLEGIA, packaged in 1030.2 mL per bag, Rx
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: oxyTOCIN 60 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Centr
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: heparin added to 0.9% sodium chloride, 7,500 units/1,000 mL* (7.5 units/mL), 100
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Modified del Nido Microplegia, packaged in 40 mL per syringe, Rx only, Central A
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: dilTIAZem added to 0.9% sodium chloride, 125 mg/125 mL* (1 mg/mL), 125 mL per ba
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: PHENYLephrine added to 0.9% sodium chloride, 20 mg/250 mL* (80 mcg/mL), 250 mL p
2023-05-31
Class II — Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
View Source
FDA Drug Recall: Virginia Hospital Center (VA) TPN Neonatal Day 1 Bag, Trophamine 5.5 gm, Dextros
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Abington Memorial Hospital (PA) TPN Neonatal Starter 0.4-0.599 Kg, Amino Acids,
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Rose Medical Center (CO) Neonate D5 Bridge, Trophamine 3% Dextrose 5%, Additives
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Spotsylvania Regional Med Ctr (VA) TPN Neonatal Starter Bag with Calcium, Troph
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Bayshore Medical Center (TX) 10% Dextrose Starter Neo TPN, Trophamine 2.4% , Dex
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Adventist Hinsdale Hospital (IL) Neonatal Starter: Troph 4%Dex5% ,Trophamine 4%
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Methodist Hospital Northlake (IN) Neo Starter TPN D5, AA2, Trophamine 2% Dextros
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Virtua West Jersey Voorhees (NJ) TPN Neonatal Starter Bag, Trophamine 3% Dextros
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Truman Medical Center Lakewood (MO) Starter TPN, Trophamine 5.25g, Dextrose 10%,
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Sinai Hospital (MD) TPN Neonatal Day 1 Bag, Trophamine 10 g, Dextrose 25 g, Addi
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Spotsylvania Regional Med Ctr (VA) TPN Neonatal Starter Bag, Trophamine 5 gm , D
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Bayshore Medical Center (TX) 5% Dextrose Starter Neo TPN, Trophamine 2.4% , Dext
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Texas Health Presbyterian Dallas Neonatal Admit TPN 4 GM, Trophamine 4g/dL, Dext
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Advocate Good Samaritan Hospital (IL) TPN Dextrose 10% Trophamine 2%, Trophamin
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Hackensack University Med Ctr (NJ) 5% Dextrose Neonatal Solution, Trophamine 3%,
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Abington Memorial Hospital (PA) TPN Neonatal Starter 0.6-0.99 Kg, Amino Acids,
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Adventist Hinsdale Hospital (IL) Neonatal Starter: Troph 2% Dex10%, Trophamine 2
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Holy Cross Hospital (MD) AA3%TPN Neonatal Day 1 Bag, Trophamine 10%/3% Dextrose
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Abington Memorial Hospital (PA) TPN Neonatal Starter> 1Kg, Amino Acids, Neonate
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: University of Alabama Birmingham TPN Neonatal Starter Bag, compound vol: 100 ml,
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Children's Hospital Colorado Springs TPN Neonate Starter Bag 4% AA/10% DEX, Trop
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Providence Hospital Southfield (MI) Neonate TPN Starter Bag, Trophamine 3g, Dext
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Bridgeport Hospital (CT)TPN Neonatal Standard Solution, Trophamine 6% Dextrose 1
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: The Medical Center of Aurora (CO) Neonate Starter 2% AA/D10W, Trophamine 2% Dext
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Rose Medical Center (CO) Neonate D10 Bridge, Trophamine 3% Dextrose 10%, Additiv
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Advocate Good Samaritan Hospital (IL) TPN Dextrose 5% Trophamine 2%, Trophamine
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Olathe Medical Center (KS) NICU TPN Starter: Ingredients per 80 ml, Trophamine 3
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Robert Wood Johnson University (NJ) Neonatal Starter 5% Dextrose, Trophamine 5%,
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Lankenau Hospital (PA) TPN Neonatal Starter Bag, Trophamine 2.5%, Dextrose 10%,
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: St Lukes East Lees Summit (MO) Protein Bag,Trophamine 5g, Dextrose 10%, Additive
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Walter Reed Natl Mil Med Ctr (MD) Stock TPN D10% with Ca, Trophamine 12g, Dextro
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Robert Wood Johnson University (NJ) Neonatal Starter 10% Dextrose, Trophamine 5%
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Truman Medical Center Lakewood (MO) Trophamine UAC Solution, Trophamine 3.2g, co
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: Walter Reed Natl Mil Med Ctr (MD) Stock TPN D10% without Ca, Trophamine 12g, Dex
2015-04-15
Class I — Non-Sterility: Out of specification results for the sterility test for microbial contamination.
View Source
FDA Drug Recall: del Nido Cardioplegia with Lidocaine 1052.8 ml, Rx Only, Central Admixture Pharm
2014-09-03
Class I — Non Sterility; microbial contamination identified as Aspergillus species
View Source
FDA Drug Recall: adenosine 90 mg in 0.9% sodium chloride/90 mL, Rx Only, Central Admixture Pharma
2014-09-03
Class I — Non Sterility; microbial contamination identified as Aspergillus species
View Source
FDA Drug Recall: PEDIATRIC CARDIOPLEGIA, 255 mL, Rx Only, Central Admixture Pharmacy Services, In
2014-09-03
Class I — Non Sterility; microbial contamination identified as Aspergillus species
View Source
FDA Drug Recall: LOW Potassium Cardioplegia 792 mL, Rx Only, Central Admixture Pharmacy Services,
2014-09-03
Class I — Non Sterility; microbial contamination identified as Aspergillus species
View Source
lobbying
1 records
Lobbying Client: CENTRAL ADMIXTURE PHARMACY SERVICES, INC.
Lobbied by POLSINELLI PC — Pharmacy services company
View Source
ny_corps
1 records
NY Corp: CENTRAL ADMIXTURE PHARMACY SERVICES, INC.
2004-08-20
FOREIGN BUSINESS CORPORATION | County: Albany | Jurisdiction: Delaware
View Source
Be informed when major changes happen on CFVA — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.